|
RPL29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.296400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.133700E-02 |
| Normal-vs-Stage2 |
3.065400E-01 |
| Normal-vs-Stage3 |
2.765600E-02 |
| Normal-vs-Stage4 |
4.167700E-02 |
| Stage1-vs-Stage2 |
5.818000E-01 |
| Stage1-vs-Stage3 |
6.573600E-01 |
| Stage1-vs-Stage4 |
3.884400E-01 |
| Stage2-vs-Stage3 |
4.737200E-01 |
| Stage2-vs-Stage4 |
3.066400E-01 |
| Stage3-vs-Stage4 |
5.701800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.819900E-03 |
| Normal-vs-AfricanAmerican |
4.703800E-01 |
| Normal-vs-Asian |
9.800100E-02 |
| Caucasian-vs-AfricanAmerican |
2.243500E-02 |
| Caucasian-vs-Asian |
9.809400E-01 |
| AfricanAmerican-vs-Asian |
6.929700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.189930E-02 |
| Normal-vs-Female |
2.852000E-02 |
| Male-vs-Female |
3.432000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.585910E-02 |
| Normal-vs-Age(41-60Yrs) |
1.265220E-01 |
| Normal-vs-Age(61-80Yrs) |
4.827600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.620400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.101400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.367000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.351800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.347200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.471200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.615600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.576600E-01 |
| Classical-VS-Follicular |
2.320200E-01 |
| Classical-VS-Other |
9.514000E-02 |
| Classical-VS-Normal |
4.348100E-02 |
| Tall-VS-Follicular |
6.109600E-01 |
| Tall-VS-Other |
3.489900E-02 |
| Tall-VS-Normal |
3.757800E-02 |
| Follicular-VS-Other |
3.407800E-01 |
| Follicular-VS-Normal |
1.427880E-02 |
| Other-VS-Normal |
4.962600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.150350E-02 |
| Normal-vs-N1 |
1.942120E-02 |
| N0-vs-N1 |
3.993200E-01 |
|
|
